Express Pharma

Sathguru and RTI International’s vaccine delivery solution bag recognition

0

Hyderabad-based Sathguru Management Consultants’ and RTI International has been recognised by Grand Challenges Canada with a grant of CAD 100,000 (Canadian dollars). Sathguru Management Consultants and RTI International have jointly developed a solution to the logistical challenge in last mile of vaccine delivery. Sathguru has been recognised among 59 peer-reviewed grantees from low and middle income countries in round 4 of the Stars in Global Health programme for creative, out of the box global health solutions. Grand Challenges Canada is funded by the Government of Canada and is dedicated to supporting bold ideas with big impact in global health. RTI is one of the world’s leading research institutes.

Sathguru’s solution is a portable and battery operated thermoelectric container developed using cutting edge technologies in collaboration with Dr Rama Venkatasubramanian, Director of North Carolina-based RTI International’s Center for Solid State Energetics. The thermoelectric container is envisioned to replace the Styrofoam and plastic boxes with ice packs that are currently used to transport vaccines to remote vaccination camps in emerging economies in Asia and Africa.

Pushpa Vijayaraghavan, Programme Lead, Sathguru believes that this solution bridges a critical gap and infrastructure challenge in vaccine delivery. She notes that while commendable milestones have been achieved in the development of vaccines, their delivery system is still stuck in a rut of age old practices.

“Unfortunately, for moving vaccines to the last mile of delivery in remote camps, we still use the styrofoam boxes and passive cooling technology used 50 years ago. While these ice packed boxes are a cost effective solution, they offer no method to regulate the temperatures in the box and vaccine loss due to temperatures ranging beyond the optimum is a widespread problem. Moreover, the short life of ice packs used significantly limits the length and efficacy of vaccination camps,” she said.

While RTI will develop field ready prototypes of the solution, Sathguru will lead the effort in field validation and commercialisation of the innovative product. Partners for field validation and commercial production are currently being finalised and will play a critical part in the development of this impactful public health product that could change the landscape of vaccine delivery in resource constrained settings.

EP News BureauMumbai

Leave A Reply

Your email address will not be published.